ERIN LOVE MCDERMOTT: Open Payments
NPI 1790269389 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 29 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $89 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $168 |
| Novo Nordisk Inc | 6 | $103 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Corcept Therapeutics | 1 | $25 |
| Astellas Pharma US Inc | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Boston Scientific Corporation | 1 | $18 |
| Edwards Lifesciences Corporation | 1 | $18 |
| Viatris Specialty LLC | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: QULIPTA, VRAYLAR, Rybelsus, UBRELVY, Wegovy, FARXIGA, Korlym, Veozah.
Industry payments across ID — which companies pay providers there.
